scispace - formally typeset
W

William J. Gordon

Researcher at Brigham and Women's Hospital

Publications -  56
Citations -  2111

William J. Gordon is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Health care & Medicine. The author has an hindex of 14, co-authored 42 publications receiving 1208 citations. Previous affiliations of William J. Gordon include University of Washington & Cornell University.

Papers
More filters
Journal ArticleDOI

Blockchain Technology for Healthcare: Facilitating the Transition to Patient-Driven Interoperability.

TL;DR: In this paper, the authors look at how blockchain technology might facilitate the transition from institution-centric to patient-centric data sharing through five mechanisms: (1) digital access rules, (2) data aggregation, (3) data liquidity, (4) patient identity and (5) data immutability.

Blockchain Technology for Healthcare: Facilitating the Transition to Patient-Driven Interoperability

TL;DR: It remains to be seen whether blockchain can facilitate the transition from institution-centric to patient-centric data sharing, as this paper looks at barriers to blockchain-enabled patient-driven interoperability.
Journal ArticleDOI

Beyond validation: getting health apps into clinical practice

TL;DR: This work proposes a framework for prescribing apps and outlines the key issues that need to be addressed to enable app dissemination in clinical care, including: education and awareness, creating digital formularies, workflow and EHR integration, payment models, and patient/provider support.
Journal ArticleDOI

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

Sara Lindström, +74 more
- 07 Nov 2019 - 
TL;DR: Mendelian randomization analyses suggested that blood traits may contribute to the underlying risk of VTE; for some loci, the association signals are likely mediated through gene expression of nearby genes.
Journal ArticleDOI

Radiation therapy in the management of patients with mesothelioma

TL;DR: The management of patients with mesothelioma requires new and innovative approaches to increase the effectiveness of radiation therapy and minimize the significant potential combined toxicity of pulmonary irradiation and adriamycin.